Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Earnings

Review historical estimates and see whether a company has beaten or missed expectations.

Last Close
Jun 21 04:00PM ET
63.22
Dollar change
+0.86
Percentage change
1.38
%
IndexS&P 500 P/E19.19 EPS (ttm)3.29 Insider Own1.62% Shs Outstand224.29M Perf Week0.85%
Market Cap14.22B Forward P/E12.46 EPS next Y5.07 Insider Trans-0.77% Shs Float221.22M Perf Month10.14%
Income745.44M PEG0.83 EPS next Q1.09 Inst Own95.60% Short Float5.27% Perf Quarter9.53%
Sales3.77B P/S3.77 EPS this Y18.72% Inst Trans0.60% Short Ratio3.67 Perf Half Y2.13%
Book/sh24.02 P/B2.63 EPS next Y21.23% ROA11.53% Short Interest11.66M Perf Year2.15%
Cash/sh17.13 P/C3.69 EPS next 5Y23.13% ROE15.13% 52W Range50.27 - 67.36 Perf YTD0.68%
Dividend Est.- P/FCF17.98 EPS past 5Y38.99% ROI13.75% 52W High-6.15% Beta0.74
Dividend TTM- Quick Ratio3.43 Sales past 5Y14.55% Gross Margin91.46% 52W Low25.76% ATR (14)1.45
Dividend Ex-Date- Current Ratio3.47 EPS Y/Y TTM127.87% Oper. Margin18.91% RSI (14)71.63 Volatility3.01% 2.20%
Employees2524 Debt/Eq0.01 Sales Y/Y TTM8.58% Profit Margin19.78% Recom2.00 Target Price71.59
Option/ShortYes / Yes LT Debt/Eq0.01 EPS Q/Q675.68% Payout0.00% Rel Volume2.94 Prev Close62.36
Sales Surprise-4.45% EPS Surprise-19.46% Sales Q/Q8.93% EarningsApr 30 BMO Avg Volume3.17M Price63.22
SMA206.58% SMA5012.65% SMA2009.17% Trades Volume9,321,942 Change1.38%
Date Action Analyst Rating Change Price Target Change
May-23-24Initiated Deutsche Bank Hold $55
Apr-23-24Initiated Cantor Fitzgerald Neutral
Feb-23-24Initiated Jefferies Buy $81
Feb-14-24Downgrade JMP Securities Mkt Outperform → Mkt Perform
Dec-13-23Upgrade Leerink Partners Market Perform → Outperform $78
Dec-04-23Upgrade Guggenheim Neutral → Buy $86
Nov-21-23Downgrade Goldman Buy → Neutral $98 → $65
Jul-25-23Initiated Citigroup Buy $82
May-04-23Downgrade BofA Securities Buy → Neutral $84
Apr-10-23Downgrade RBC Capital Mkts Outperform → Sector Perform $81 → $79
Jun-14-24 03:00PM
Jun-13-24 08:00AM
Jun-11-24 08:00AM
Jun-07-24 04:30PM
May-30-24 04:05PM
11:31AM Loading…
11:31AM
May-21-24 01:15PM
08:00AM
May-17-24 12:24PM
May-14-24 05:00PM
03:18AM
May-13-24 05:24PM
05:23PM
01:49PM
12:41PM
10:57AM Loading…
10:57AM
09:24AM
09:14AM
08:24AM
07:00AM
May-12-24 08:26AM
May-10-24 03:17PM
May-09-24 06:15AM
May-02-24 11:17PM
08:00AM
May-01-24 11:24AM
11:12AM
10:53AM
10:33AM
10:20AM
08:55AM Loading…
08:55AM
07:58AM
07:50AM
Apr-30-24 04:31PM
02:57PM
11:54AM
11:50AM
10:10AM
09:36AM
09:30AM
08:34AM
07:10AM
07:00AM
Apr-23-24 10:12AM
10:01AM
09:44AM
07:00AM
Apr-15-24 05:30AM
Apr-11-24 08:00AM
Apr-06-24 08:56AM
Apr-01-24 08:30AM
08:30AM
Mar-31-24 11:53AM
Mar-29-24 04:30PM
Mar-26-24 02:47PM
Mar-17-24 08:50AM
Mar-15-24 10:37AM
Mar-14-24 11:30AM
08:18AM
Mar-12-24 01:52PM
Mar-11-24 01:02PM
07:18AM
Mar-10-24 04:05PM
04:05PM
Mar-07-24 03:00PM
Mar-04-24 08:00AM
Mar-03-24 08:29AM
Feb-29-24 10:19AM
07:30AM
Feb-28-24 01:10PM
Feb-27-24 04:08PM
Feb-26-24 03:20PM
Feb-21-24 04:50PM
Feb-15-24 08:00AM
Feb-14-24 09:32AM
01:15AM
12:12AM
Feb-13-24 05:43PM
11:37AM
09:30AM
08:26AM
08:25AM
07:38AM
07:35AM
07:34AM
07:00AM
Feb-09-24 11:03AM
09:15AM
Feb-07-24 08:55AM
Feb-06-24 04:30AM
Feb-05-24 06:54PM
04:46PM
Jan-31-24 07:33PM
Jan-30-24 11:07AM
Jan-26-24 09:12AM
Jan-24-24 08:39AM
Jan-23-24 08:00AM
Jan-18-24 04:00PM
Jan-08-24 08:30AM
Jan-06-24 11:02AM
Incyte Corp. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of proprietary therapeutics. It focuses on hematology and oncology, and inflammation and autoimmunity therapeutic areas. The company was founded in April 1991 and is headquartered in Wilmington, DE.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Flannelly Barry PEVP & General Manager USJun 12 '24Sale60.0019,1641,149,84066,377Jun 14 12:17 PM
Tray ThomasPrincipal Accounting OfficerJun 06 '24Sale58.911,09364,38921,634Jun 10 12:25 PM
BAKER BROS. ADVISORS LPDirectorMay 07 '24Option Exercise49.0130,0001,470,30033,462,981May 09 06:25 PM
Stein Steven HEVP & Chief Medical OfficerJan 03 '24Sale65.517,365482,48190,218Jan 05 12:27 PM
Iyengar Vijay KEVP, GMAPPSJan 02 '24Sale65.0065742,70543,412Jan 04 01:05 PM
Tray ThomasPrincipal Accounting OfficerDec 13 '23Sale62.371,06766,54923,436Dec 14 02:11 PM
Tray ThomasPrincipal Accounting OfficerDec 12 '23Sale57.3621012,04624,503Dec 14 02:11 PM
SWAIN PAULA JEVP, Human ResourcesSep 01 '23Sale65.138,449550,28377,530Sep 06 04:00 PM
Stein Steven HEVP & Chief Medical OfficerAug 01 '23Sale63.2821,5111,361,21697,583Aug 03 04:00 PM